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doi:10.1016/j.kjms.2011.10.002Abstract We report the case of a woman 33 years of age with infective endocarditis-related
intracranial mycotic aneurysm (IMA) caused by a Streptococcus sanguinis infection. The
clinical diagnosis was confirmed by the findings of magnetic resonance imaging, magnetic
resonance angiographic (MRA) studies, echocardiographic studies, and a positive blood culture
result. She underwent antimicrobial treatment only (ceftriaxone intravenously for 8 weeks and
penicillin V orally for 6 weeks). The regression and disappearance of IMA were demonstrated by
a series of MRA follow-up studies.
Copyright ª 2012, Elsevier Taiwan LLC. All rights reserved.Introduction
Intracranial mycotic aneurysm (IMA) is an uncommon but
potentially fatal cerebrovascular disease [1,2] that includes
the presence of infection and the destruction of the walls
of vessels. IMA also carries a high risk of rupture and fatal
bleeding if adequate treatment is not received. There are
no standard guidelines for IMA management at this time;t of Neurology, Chang Gung
Pei Road, Niao Sung Hsiang,
inet.net (W.-N. Chang).
vier Taiwan LLC. All rights reservantimicrobial therapy with/without surgical or endovas-
cular intervention can be an option to consider. The choice
of therapeutic methods depend, at least in part, on the
radiologic characteristics of IMA and the clinical condition
of the patient. In this study, we report a woman with
mycotic aneurysm of the left posterior cerebral artery
(PCA) caused by a Streptococcus sanguinis infection who
was successfully treated with antibiotics. A series of follow-
up neuroimaging findings are also demonstrated.
Case report
On September 3, 2009, a woman aged 33 years presented
to our emergency department (ED) with a sudden onset ofed.
Streptococcus sanguinis intracranial mycotic aneurysm 179headache lasting for 4 days. Her past history included
rheumatic heart disease and iron deficiency anemia.
Meanwhile, she also had a low-grade fever for a 6-month
period before this ED visit. Physical examination revealed
that her consciousness was clear, but she was in a state of
acute illness. Her heart rate was 118 beats per minute;
body temperature, 38.5 C; respiratory rate, 20 breaths per
minute; and blood pressure, 120/70 mm Hg. Except cardiac
auscultation revealing systolic cardiac murmur, the results
of other physical and neurologic examinations were all
within normal limits. A chest X-ray was normal and an
electrocardiogram showed a normal sinus rhythm with
normal conduction intervals. Laboratory examinations
showed a white blood cell (WBC) count of 10.2  103/mL
(normal range, 3.5e11  103/mL) with 86% neutrophils
(normal range, 42e74%), hemoglobin 9.0 g/dL (normal
range, 12e16 g/dL), and an erythrocyte sedimentation rate
of 50 mm/hour (normal range, 0e15 mm/hour). Her
hemoglobin level, which was checked 3 months earlier, was
11.3 g/dL. Other extended metabolic panel and coagulation
studies were all within normal limits.
At the ED visit, computed tomography (CT) of the brain
revealed an enhancement of tentorial meninges (Fig. 1A).
Cerebrospinal fluid (CSF) analysis revealed a WBC count of
400/cm3 (normal range, 0e5/cm3), neutrophil count of
66%, glucose 41 mg/dL (normal range, 40e70 mg/dL), total
protein 71.7 mg/dL (normal range, 15e45 mg/dL), and
lactate 25.9 mg/dL (normal range, 10.8e18.9 mg/dL).
Gram staining of the CSF did not yield any evidence
of a pathogen. After CSF and blood samples were collected
for cultures, the patient received intravenous vancomycin
(2 g/day) and ceftriaxone (4 g/day) therapy. The CSF
cultures revealed no growth, while the growth of S san-
guinis in blood cultures (2/2) was identified using the
Phoenix SMIC/ID-8 panel (Becton, Dickinson and Co.,
Sparks, MD, USA). The antibiogram of this S sanguinis strain,
as tested by the Kirby-Bauer disc diffusion method (BBL
Mueller-Hinton II agar purchased from Becton, Dickinson
and Company, NJ, USA), showed its susceptibility to cef-
triaxone, penicillin, teicoplanin, and vancomycin.
After admission, the patient underwent further evalua-
tion using cardiac and brain magnetic resonance imagingFigure 1. (A) Brain computed tomography with contrast enhanc
dimensional echocardiography reveals oscillating vegetation over t(MRI). Transthoracic and transesophageal echocardiography
revealed a prolapse of the mitral and tricuspid valves,
chordae rupture of the anterior and posterior mitral leaf-
lets, and oscillating vegetation over the anterior and
posterior mitral valves (Fig. 1B). Magnetic resonance angi-
ography (MRA) of the brain preformed on the fifth day of
admission revealed an abnormal dilatation of the distal
part of the left PCA (Figs. 2A and 2C) that was compatible
with the finding of mycotic aneurysm. Additionally, hyper-
intensity of a T2-weighted image (Fig. 2B) was also noted
in this MRI study that may have denoted a perifocal
inflammation. Because of her cardiac condition, the patient
did not receive interventional therapy for IMA; only anti-
microbial treatment was administered. After the result
from the final confirmatory test for the identification of
S sanguinis was available, we discontinued the use of van-
comycin, and the patient received an 8-week course of
intravenous ceftriaxone therapy (4 g/day) followed by
a 6-week course of oral penicillin V (1 g/day).
On October 4, 2009, a second MRI follow-up study was
performed, and the results (Fig. 2D) showed a regression of
IMA. Third (Fig. 2E) and fourth (Fig. 2F) MRI follow-up
studies were performed on December 16, 2009 and July 8,
2010, respectively, and all the results showed the disap-
pearance of IMA. During the therapeutic course, the patient
underwent mitral valve repair on January 11, 2010. Her
postoperative course went smoothly, and no new neuro-
logic problems developed over a 10-month follow-up
period.Discussion
The leading predisposing conditions for the development of
IMA may include meningitis, cavernous sinus thrombosis,
and cardiac disorders, such as infective endocarditis (IE)
[1e3]. The clinical presentation, findings of echocardiog-
raphy and MRA studies, and the presence of the S sanguinis
bacteremia in this 33-year-old woman confirmed the diag-
nosis of IE-related IMA [3]. The IMA was located in the distal
part of the PCA; this finding is consistent with that of
previous reports [1e4], which postulated that the IMAs,ement reveals bilateral enhanced tentorium (arrow); (B) two-
he anterior and posterior mitral valves (arrow).
Figure 2. (A and C) A mycotic aneurysm (arrow) is observed in the distal part of the left posterior cerebral artery on magnetic
resonance angiography (MRA); (B) shows a hyperintensity lesion (arrow) in a T2-weighted image on magnetic resonance imaging
(MRI); (D) shows a regression of mycotic aneurysm on the MRA (arrow, Oct 4, 2009); (E) (December 16, 2009); and (F) (July 8, 2010)
show the disappearance of the mycotic aneurysm (arrow).
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often distal in distribution. The occurrence of neurologic
complications in IE can be as high as 30% [3]. Among the
complications, IMA is the most devastating [3,5]. Although
neurologic features, such as sudden-onset headache and
fever as presented by the present patient, are common in
IMA [2,6e9], some of the IMAs are clinically silent [1].
Therefore, the exact incidence of IMA in IE is actually
underestimated. IMA in the present patient was detected
by MRA studies; in addition, as shown in Fig. 2B, a perifocal
inflammatory change was noted. For this particular infec-
tious syndrome, noninvasive brain MRI and MRA studies may
serve as important tools for clinical diagnosis.
S aureus and S spp. are the common implicated patho-
gens of IMA [1e3]. S sanguinis, as revealed through the
blood culture of the present patient, is a member of the
S mitis group, which includes several species of known
clinical significance, and it is also a common causative
pathogen of IMA [3,10e12]. This patient planned to undergo
open-heart surgery (mitral valve repairment) in which she
may have needed anticoagulation therapy during operative
procedures. Therefore, a “complete” treatment of IMA
was required for the open-heart procedure in order to
avoid a rupture of IMA and intracranial bleeding. Antimi-
crobial treatment alone helped in the gradual regression of
S sanguiniserelated IMA and its disappearance after a 3.5-
month follow-up MRA study. This is the reason why our
patient received a prolonged course of antibiotic treat-
ment, i.e., MRA finding-guided antimicrobial treatment. We
discontinued the antibiotic treatment after the IMA dis-
appeared in an MRA follow-up study. The disappearance of
IMA was further confirmed with another MRA follow-up
study 10 months later. In clinical practice, the treatment
of unruptured IMA is still a controversial issue [1]. It hasbeen reported that antimicrobial treatment of unruptured
IMA, when used as a sole treatment, may bring a 29%
disappearance of the aneurysm, 18.5% regression of the
aneurysm, 15% stationary state of the aneurysm, and 22%
enlargement of the aneurysm [1]. In the study reported by
Chapot and colleagues [13], the causative pathogens were
heterogeneous, and the follow-up durations ranged from
1 to 12 weeks only. Therefore, it is difficult to assess the
effect of antimicrobial treatment alone on a specific
pathogen-related IMA. Nevertheless, close following-up of
the neurological states and a closer monitoring of the
change of IMA by using neuroimaging studies are mandatory
in the course of sole antimicrobial treatment of IMA caused
by bacterial infection.Conclusion
In this report, we demonstrated a series of four follow-up
MRI studies in a patient with IE-related IMA caused by
a S sanguinis infection. The effect of the antimicrobial
therapy was followed up during a 10-month period. MRA,
without invasive cerebral angiographic study, at least for
this patient, can be a good complementary tool for IMA
diagnosis and therapeutic follow-up study. However, for
a better delineation of this specific pathogen-related IMA,
further large-group studies are needed.References
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